Prognostic value of thrombocytosis in renal cell carcinoma.
about
Paraneoplastic thrombocytosis: the secrets of tumor self-promotionAssessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancerThe association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.Targeting the endothelin axis with atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinomaBaseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma.Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949.How useful is thrombocytosis in predicting an underlying cancer in primary care? a systematic review.Prognostic factors in localized renal cell cancer.Prognostic factors in renal cell cancer.Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinomaQuality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfaIn search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma.Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis.Is thrombocytosis a useful prognostic marker in renal cell carcinoma? Results of a single-center retrospective analysisWhen to perform preoperative chest computed tomography for renal cancer staging.Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma.Impact of preoperative thrombocytosis on prognosis after surgical treatment in pathological T1 and T2 renal cell carcinoma: results of a multi-institutional comprehensive study.Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma.Renal Cell Carcinoma with Paraneoplastic Manifestations: Imaging with CT and F-18 FDG PET/CTCorrelation of percentage changes in platelet counts with recurrence rate following radical nephrectomy.Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma.Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug.Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence.A Temporal Examination of Platelet Counts as a Predictor of Prognosis in Lung, Prostate, and Colon Cancer Patients.Nierenzellkarzinom
P2860
Q26825427-0DA32DC2-0AC7-4129-95A5-F4320655CCAAQ33685545-67F85427-3A44-4ABE-B8A3-5CD6AFEA9E86Q35625163-D2B21844-DFDA-4BFB-93AB-54C0CA679BA8Q35681948-C6CDAEAE-6860-4034-9AF5-42BFF34142C3Q35879829-3E4CD792-B6AD-4528-8FA3-21BB87C61591Q36088918-E1C42845-C828-490A-8C71-432D97E26EABQ36147153-82FF3BCE-EBBA-48E4-8F2D-8C52CDCB538CQ36794758-4C50C756-1D64-4AFD-A0F5-697312D99A49Q36794803-07DC0959-3342-4B9C-A51D-2C4E5531A69BQ37068809-47714918-5A81-4E5D-9DE5-40979668558EQ37466388-0A42B6AD-CE2A-4B82-AD12-5949DFC86FFCQ37765585-1EDD34C0-39DC-45FF-96F2-85A0AA65F6B1Q37794048-1AEA3A1F-C621-4220-A3FC-81BBC7385F52Q38333820-BC12EB59-8855-4AE4-936E-AA1FE019FCA6Q39339598-1BD50D1A-BFFC-463F-B5A7-63363C514B66Q40836247-54257D13-1DEE-4981-883F-F462F4DF6847Q41933788-24BCC614-037B-4C0B-BA03-705CA43562F7Q41966109-5EE0B3FB-9B0D-44A8-894B-6A748037D55DQ42176899-4E7427D4-E72C-4399-B7A0-5899023A9F43Q42427374-1BF2254F-6338-4DFA-AE02-E197102F9957Q42596645-1E4E437A-A3EE-4966-9458-13753A74CF7BQ44216237-3F7769CF-AB10-4336-B2EF-10A3B2C8F06AQ47229243-57042BEF-B8A9-47FF-9E3C-6FB67CB0DC7BQ47400340-3F91C293-FC94-470E-9434-41F7FD229364Q54578801-7E31FF30-71F6-4AC6-ABCC-01E157E816D1Q54936867-D4678A3A-4039-4F55-91AE-39027E4F28D0Q56639125-BC3CCEEF-5705-4248-84F4-64A1133D2DCE
P2860
Prognostic value of thrombocytosis in renal cell carcinoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prognostic value of thrombocytosis in renal cell carcinoma.
@ast
Prognostic value of thrombocytosis in renal cell carcinoma.
@en
Prognostic value of thrombocytosis in renal cell carcinoma.
@nl
type
label
Prognostic value of thrombocytosis in renal cell carcinoma.
@ast
Prognostic value of thrombocytosis in renal cell carcinoma.
@en
Prognostic value of thrombocytosis in renal cell carcinoma.
@nl
prefLabel
Prognostic value of thrombocytosis in renal cell carcinoma.
@ast
Prognostic value of thrombocytosis in renal cell carcinoma.
@en
Prognostic value of thrombocytosis in renal cell carcinoma.
@nl
P2093
P1476
Prognostic value of thrombocytosis in renal cell carcinoma.
@en
P2093
Emmanuelle Leray
François Guillé
Jacques Tostain
Karim Bensalah
Patricia Fergelot
P304
P356
10.1016/S0022-5347(05)00526-4
P407
P433
P577
2006-03-01T00:00:00Z